Related references
Note: Only part of the references are listed.Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial
Anne Katrine Pagsberg et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2022)
Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis
Viswam Subeesh et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial
Jingmei Xiao et al.
FRONTIERS IN PSYCHIATRY (2021)
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Early prediction of clinical response in first episode schizophrenia (FES) patients receiving olanzapine
Viswam Subeesh et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2020)
How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials
Myrto T. Samara et al.
SCHIZOPHRENIA BULLETIN (2019)
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
Yi-Lung Chen et al.
BMC PSYCHIATRY (2018)
Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia
C. -H. Lin et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Does early antipsychotic response predict long-term treatment outcome?
Sean A. Rasmussen et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care
Alkomiet Hasan et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine
Sean A. Rasmussen et al.
PSYCHIATRY RESEARCH (2016)
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review
Myrto T. Samara et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial
Marie Stentebjerg-Olesen et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2015)
Initial Severity of Schizophrenia and Efficacy of Antipsychotics Participant-Level Meta-analysis of 6 Placebo-Controlled Studies
Toshi A. Furukawa et al.
JAMA PSYCHIATRY (2015)
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta- analysis of randomized controlled trials
Taro Kishi et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
Determinants of Antipsychotic Response in Schizophrenia: Implications for Practice and Future Clinical Trials
Jonathan Rabinowitz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Early Antipsychotic Response to Aripiprazole in Adolescents With Schizophrenia: Predictive Value for Clinical Outcomes
Christoph U. Correll et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2013)
Equipercentile linking of the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale in a catchment area
Stefan Leucht et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia
Haya Ascher-Svanum et al.
BMC PSYCHIATRY (2011)
Time to Treatment Response in First-Episode Schizophrenia: Should Acute Treatment Trials Last Several Months?
Juan A. Gallego et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
Virginia L. Stauffer et al.
PSYCHIATRY RESEARCH (2011)
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia
Kotaro Hatta et al.
SCHIZOPHRENIA RESEARCH (2011)
Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials
Virginia Stauffer et al.
SCHIZOPHRENIA RESEARCH (2011)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation
S. Leucht et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia
W. Wolfgang Fleischhacker et al.
BIOLOGICAL PSYCHIATRY (2009)
Early- and Delayed Antipsychotic Response and Prediction of Outcome in 528 Severely Impaired Patients with Schizophrenia Treated with Amisulpride
M. Lambert et al.
PHARMACOPSYCHIATRY (2009)
Optimal thresholds of early response to atypical antipsychotics: Application of signal detection methods
Lei Chen et al.
SCHIZOPHRENIA RESEARCH (2009)
Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia
Bruce J. Kinon et al.
SCHIZOPHRENIA RESEARCH (2008)
Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI
Stephen Z. Levine et al.
SCHIZOPHRENIA RESEARCH (2008)
Optimizing early prediction for antipsychotic response in schizophrenia
Yue-Cune Chang et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Share Paper
